潤邦股份(002483.SZ)延期回覆深交所2019年半年報問詢函
格隆匯10月21日丨潤邦股份(002483.SZ)公佈,公司於2019年10月14日收到深圳證券交易所《關於對江蘇潤邦重工股份有限公司2019年半年報的問詢函》(中小板半年報問詢函【2019】第71號)(“《問詢函》”),要求公司在2019年10月22日前將有關説明材料報送深圳證券交易所中小板公司管理部並對外披露,同時抄報江蘇證監局上市公司監管處。
公司收到《問詢函》後,積極組織相關部門對《問詢函》中所涉及的問題進行逐項核實和回覆。由於《問詢函》中部分問題的回覆尚需進一步補充和完善,經向深圳證券交易所申請,公司將延期回覆《問詢函》。公司將盡快完成《問詢函》回覆工作,並及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.